Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Viral (RSV) Infections”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07128121
What this trial is testing

Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Shenzhen Shenxin Biotechnology Co., Ltd 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06143046
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 360
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Not applicableStudy completedNCT01090557
What this trial is testing

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Who this might be right for
RSV InfectionBronchiolitis
Winthrop University Hospital 60
Early research (Phase 1)Looking for participantsNCT06645665
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd 240
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Not applicableUnknownNCT05277298
What this trial is testing

Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa

Who this might be right for
SARS-CoV-2 InfectionInfluenzaRespiratory Syncytial Virus (RSV)
National Institute for Communicable Diseases, South Africa 1,200
Large-scale testing (Phase 3)Study completedNCT06060457
What this trial is testing

Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,900
Post-approval studies (Phase 4)Looking for participantsNCT05045612
What this trial is testing

Antibiotic Therapy in Viral Airway Infections

Who this might be right for
Infectious DiseaseInfluenzaRespiratory Syncytial Virus (RSV)+1 more
University Hospital, Akershus 380
Testing effectiveness (Phase 2)Study completedNCT02718937
What this trial is testing

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Biota Pharma Europe Limited 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06067230
What this trial is testing

Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,153
Not applicableEnded earlyNCT05105191
What this trial is testing

Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room

Who this might be right for
Influenza Viral InfectionsRSV Infection
Erasme University Hospital 280
Early research (Phase 1)Study completedNCT02558413
What this trial is testing

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT04068792
What this trial is testing

A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease

Who this might be right for
Respiratory Syncytial Viruses
Janssen Research & Development, LLC 22
Not applicableStudy completedNCT05268939
What this trial is testing

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19

Who this might be right for
COVID-19Influenza AInfluenza Type B+1 more
LumiraDx UK Limited 668
Testing effectiveness (Phase 2)Study completedNCT04138056
What this trial is testing

A Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 509
Very early researchStudy completedNCT05148780
What this trial is testing

Acute Respiratory Infections in Global Outpatient Setting

Who this might be right for
Acute Respiratory Infection
Janssen Research & Development, LLC 245
Testing effectiveness (Phase 2)Study completedNCT02654171
What this trial is testing

Viral Inhibition in Children for Treatment of RSV

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Shanghai Ark Biopharmaceutical Co., Ltd. 72
Not applicableActive Not RecruitingNCT06077968
What this trial is testing

Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Viruses
Pfizer 1
Load More Results